Brief: BioRestorative Announces Clinical Trial Contract With Second Site For Phase 2 Clinical Trial To Treat CLDD
June 22 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ANNOUNCES CLINICAL TRIAL CONTRACT
WITH
SECOND SITE FOR THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT
CHRONIC LUMBAR DISC DISEASE (CLDD)
Source text for Eikon: ID:nGNX3n1fT6
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM